Intravenous Streptokinase in Acute Myocardial Infarction
Status:
Completed
Trial end date:
1994-10-01
Target enrollment:
Participant gender:
Summary
To determine whether the administration of intravenous streptokinase (SK) early in the course
of acute, transmural myocardial infarction would limit myocardial damage.